Groupama Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7M Sell
29,879
-2,015
-6% -$852K 0.15% 77
2026
Q1
$15.1M Buy
31,894
+1,599
+5% +$805K 0.22% 71
2025
Q4
$14.1M Sell
30,295
-15
-0% -$6.96K 0.21% 73
2025
Q3
$12.9M Sell
30,310
-30,313
-50% -$11.7M 0.19% 70
2025
Q2
$23M Buy
60,623
+2,597
+4% +$936K 0.38% 54
2025
Q1
$19.9M Buy
58,026
+10,895
+23% +$3.5M 0.4% 53
2024
Q4
$14.1M Buy
47,131
+7,601
+19% +$2.66M 0.29% 67
2024
Q3
$12.9M Sell
39,530
-30,862
-44% -$11.3M 0.34% 61
2024
Q2
$11.9M Buy
70,392
+66,803
+1,861% +$21.7M 0.16% 87
2024
Q1
$11.7M Sell
3,589
-30,632
-90% -$9.36M 0.21% 87
2023
Q4
$8.39M Buy
+34,221
New +$8.46M 0.22% 87

Other funds holding HCA

Groupama Asset Management's HCA Position: Q2 2026 in Review

Groupama Asset Management reduced its HCA Healthcare (HCA) stake by 6.3% in Q2 2026, selling an estimated $852K and leaving 29,879 shares worth $11.7M. The position accounts for 0.15% of the portfolio, ranked #77.

Groupama Asset Management first reported a position in HCA in Q4 2023 and has held it in 11 quarters since. The position peaked at $23M in Q2 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Groupama Asset Management held 29,879 shares of HCA Healthcare worth $11.7M as of Q2 2026.
  • Groupama Asset Management sold 2,015 HCA Healthcare shares in Q2 2026, an estimated $852K.
  • HCA Healthcare made up 0.15% of Groupama Asset Management's portfolio in Q2 2026, its #77 holding.
  • Groupama Asset Management first reported a position in HCA Healthcare in Q4 2023 and has held it in 11 quarters since.
  • Groupama Asset Management's HCA Healthcare position peaked at $23M in Q2 2025.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.